{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:44:01Z","timestamp":1793040241628,"version":"4.5.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pet.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["PET Clinics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.cpet.2026.05.007","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T21:52:49Z","timestamp":1782856369000},"page":"541-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["18F-fluorodeoxyglucose PET in Major Psychiatric Disorders"],"prefix":"10.1016","volume":"21","author":[{"given":"Rodolfo","family":"Ferrando","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Artur Martins","family":"Coutinho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.cpet.2026.05.007_bib1","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/RLU.0000000000000487","article-title":"Historic images in nuclear medicine: 1976: the first issue of Clinical Nuclear Medicine and the first human FDG study","volume":"39","author":"Hess","year":"2014","journal-title":"Clin Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2026.05.007_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1161\/01.RES.44.1.127","article-title":"The [18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man","volume":"44","author":"Reivich","year":"1979","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.007_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1161\/01.RES.18.3.237","article-title":"Regional cerebral blood flow in man determined by the intra-arterial injection of an inert gas (133Xe)","volume":"18","author":"Ingvar","year":"1966","journal-title":"Circ Res"},{"key":"10.1016\/j.cpet.2026.05.007_bib4","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.cpet.2014.07.005","article-title":"Fluorodeoxyglucose PET in neurology and psychiatry","volume":"9","author":"Sch\u00f6ll","year":"2014","journal-title":"Pet Clin"},{"key":"10.1016\/j.cpet.2026.05.007_bib5","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.2967\/jnumed.116.176156","article-title":"Quantification of task-specific glucose metabolism with constant infusion of 18F-FDG","volume":"57","author":"Hahn","year":"2016","journal-title":"J Nucl Med"},{"issue":"Suppl 2","key":"10.1016\/j.cpet.2026.05.007_bib6","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.2967\/jnumed.124.268754","article-title":"SNMMI procedure Standard\/EANM practice guideline for brain [18F]FDG PET imaging, version 2.0","volume":"66","author":"Arbizu","year":"2025","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2026.05.007_bib7","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1600-0447.1974.tb09707.x","article-title":"Abnormalities of cerebral blood flow distribution in patients with chronic schizophrenia","volume":"50","author":"Ingvar","year":"1974","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.cpet.2026.05.007_bib8","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1111\/j.1600-0447.2004.00376.x","article-title":"Hypofrontality in schizophrenia: a meta-analysis of functional imaging studies","volume":"110","author":"Hill","year":"2004","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.cpet.2026.05.007_bib9","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.1017\/S003329172200174X","article-title":"Brain glucose metabolism in schizophrenia: a systematic review and meta-analysis of 18FDG-PET studies in schizophrenia","volume":"53","author":"Townsend","year":"2023","journal-title":"Psychol Med"},{"key":"10.1016\/j.cpet.2026.05.007_bib10","first-page":"935","article-title":"Prefrontal and temporal blood flow in schizophrenia: resting and activation HMPAO-SPECT patterns in young neuroleptic-naive patients with acute disease","volume":"35","author":"Catafau","year":"1994","journal-title":"J Nucl Med"},{"key":"10.1016\/j.cpet.2026.05.007_bib11","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1001\/archpsyc.1986.01800020020004","article-title":"Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: I. Regional cerebral blood flow evidence","volume":"43","author":"Weinberger","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1001\/archpsyc.1986.01800020032005","article-title":"Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia: II. Role of medication, attention, and mental effort","volume":"43","author":"Berman","year":"1986","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib13","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1037\/0894-4105.12.3.399","article-title":"Frontotemporal cerebral blood flow change during executive and declarative memory tasks in schizophrenia: a positron emission tomography study","volume":"12","author":"Ragland","year":"1998","journal-title":"Neuropsychology"},{"key":"10.1016\/j.cpet.2026.05.007_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s004060170055","article-title":"Hypofrontality in neuroleptic-naive schizophrenic patients during the Wisconsin card sorting Test--a fMRI study","volume":"251","author":"Riehemann","year":"2001","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.007_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4103\/0019-5545.31577","article-title":"Regional brain metabolism in schizophrenia: an FDG-PET study","volume":"48","author":"Seethalakshmi","year":"2006","journal-title":"Indian J Psychiatry"},{"issue":"10","key":"10.1016\/j.cpet.2026.05.007_bib16","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/MNM.0b013e328302cd10","article-title":"Fluordeoxyglucose-PET study in first-episode schizophrenic patients during the hallucinatory state, after remission and during linguistic-auditory activation","volume":"29","author":"Parellada","year":"2008","journal-title":"Nucl Med Commun"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.007_bib17","doi-asserted-by":"crossref","first-page":"324","DOI":"10.9758\/cpn.2018.16.3.324","article-title":"Neural signature for auditory hallucinations in schizophrenia: a high-resolution positron emission tomography study with fludeoxyglucose (18F)","volume":"16","author":"Kim","year":"2018","journal-title":"Clin Psychopharmacol Neurosci"},{"issue":"1","key":"10.1016\/j.cpet.2026.05.007_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084987","article-title":"Brain metabolism during hallucination-like auditory stimulation in schizophrenia","volume":"9","author":"Horga","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cpet.2026.05.007_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-1781(88)90134-5","article-title":"Positron emission tomography and subcortical glucose metabolism in schizophrenia","volume":"24","author":"Resnick","year":"1988","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.cpet.2026.05.007_bib20","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0920-9964(88)90039-4","article-title":"Brain interactions in chronic schizophrenics under resting and activation conditions","volume":"1","author":"Volkow","year":"1988","journal-title":"Schizophr Res"},{"key":"10.1016\/j.cpet.2026.05.007_bib21","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1176\/ajp.142.5.564","article-title":"Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography","volume":"142","author":"Wolkin","year":"1985","journal-title":"Am J Psychiatry"},{"issue":"17","key":"10.1016\/j.cpet.2026.05.007_bib22","doi-asserted-by":"crossref","first-page":"9235","DOI":"10.1073\/pnas.93.17.9235","article-title":"Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects","volume":"93","author":"Laruelle","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"10.1016\/j.cpet.2026.05.007_bib23","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/archgenpsychiatry.2012.169","article-title":"The nature of dopamine dysfunction in schizophrenia and what this means for treatment","volume":"69","author":"Howes","year":"2012","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.007_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nn804","article-title":"Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia","volume":"5","author":"Meyer-Lindenberg","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.cpet.2026.05.007_bib25","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2215-0366(18)30268-2","article-title":"The relationship between cortical glutamate and striatal dopamine in first-episode psychosis: a cross-sectional multimodal PET and magnetic resonance spectroscopy imaging study","volume":"5","author":"Jauhar","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib26","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0006-3223(00)00976-8","article-title":"Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: implications for schizophrenia","volume":"48","author":"Kegeles","year":"2000","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib27","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1176\/ajp.153.1.41","article-title":"Functional sites of neuroleptic drug action in the human brain: PET\/FDG studies with and without haloperidol","volume":"153","author":"Holcomb","year":"1996","journal-title":"Am J Psychiatry"},{"issue":"2","key":"10.1016\/j.cpet.2026.05.007_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/jcbfm.1985.26","article-title":"Positron emission tomography in schizophrenic patients with and without neuroleptic medication","volume":"5","author":"DeLisi","year":"1985","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.cpet.2026.05.007_bib29","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1176\/ajp.151.10.1430","article-title":"Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs","volume":"151","author":"Chakos","year":"1994","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.cpet.2026.05.007_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00213-004-1981-9","article-title":"Cerebral metabolic changes induced by clozapine in schizophrenia and related to clinical improvement","volume":"178","author":"Molina","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.cpet.2026.05.007_bib31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0006-3223(02)01602-5","article-title":"Functional effects of antipsychotic drugs: comparing clozapine with haloperidol","volume":"53","author":"Lahti","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib32","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.schres.2005.05.009","article-title":"Review of longitudinal functional neuroimaging studies of drug treatments in patients with schizophrenia","volume":"78","author":"Davis","year":"2005","journal-title":"Schizophr Res"},{"issue":"1","key":"10.1016\/j.cpet.2026.05.007_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/sj.npp.1300312","article-title":"Clozapine but not haloperidol re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex","volume":"29","author":"Lahti","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cpet.2026.05.007_bib34","series-title":"Grundrisse der Psychiatrie","author":"Wernicke","year":"1906"},{"key":"10.1016\/j.cpet.2026.05.007_bib35","series-title":"Dementia praecox or the group of schizophrenias","author":"Bleuler","year":"1911"},{"key":"10.1016\/j.cpet.2026.05.007_bib37","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1176\/ajp.149.7.890","article-title":"Evidence of dysfunction of a prefrontal-limbic network in schizophrenia: a magnetic resonance imaging and regional cerebral blood flow study of discordant monozygotic twins","volume":"149","author":"Weinberger","year":"1992","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.cpet.2026.05.007_bib38","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-2007-994982","article-title":"Aspects of cerebral connectivity in schizophrenia. A comparative CBF study on treated schizophrenics before and after medication","volume":"67","author":"Erkwoh","year":"1999","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.cpet.2026.05.007_bib39","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/archpsyc.62.4.379","article-title":"Regionally specific disturbance of dorsolateral prefrontal\u2013hippocampal functional connectivity in schizophrenia","volume":"62","author":"Meyer-Lindenberg","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib40","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0920-9964(97)00140-0","article-title":"The disconnection hypothesis","volume":"30","author":"Friston","year":"1998","journal-title":"Schizophr Res"},{"key":"10.1016\/j.cpet.2026.05.007_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/s41537-024-00535-4","article-title":"Addressing brain metabolic connectivity in treatment-resistant schizophrenia: a novel graph theory-driven application of 18F-FDG-PET with antipsychotic dose correction","volume":"10","author":"De Simone","year":"2024","journal-title":"Schizophr"},{"issue":"Suppl 2","key":"10.1016\/j.cpet.2026.05.007_bib42","doi-asserted-by":"crossref","first-page":"ii74","DOI":"10.1093\/ijnp\/pyaf052.147","article-title":"A novel graph theory-driven application of 18F-FDG-PET with antipsychotic dose correction and a machine learning approach to capture discrete brain metabolic connectivity in treatment-resistant schizophrenia","volume":"28","author":"de Bartolomeis","year":"2025","journal-title":"Int J Neuropsychopharmacol"},{"issue":"12","key":"10.1016\/j.cpet.2026.05.007_bib43","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archpsyc.1992.01820120015004","article-title":"Regional cerebral blood flow in monozygotic twins discordant and concordant for schizophrenia","volume":"49","author":"Berman","year":"1992","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib44","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1192\/bjp.175.4.357","article-title":"Altered cerebral perfusion measured by SPECT in relatives of patients with schizophrenia. Correlations with memory and P300","volume":"175","author":"Blackwood","year":"1999","journal-title":"Br J Psychiatry"},{"issue":"20","key":"10.1016\/j.cpet.2026.05.007_bib45","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/hmg\/11.20.2517","article-title":"Pharmacogenomics in schizophrenia: the quest for individualized therapy","volume":"11","author":"Basile","year":"2002","journal-title":"Hum Mol Genet"},{"issue":"1","key":"10.1016\/j.cpet.2026.05.007_bib46","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/sj.mp.4001191","article-title":"D1 receptor alleles predict PET metabolic correlates of clinical response to clozapine","volume":"8","author":"Potkin","year":"2003","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib47","series-title":"Pharmacogenetics of psychotropic drugs","article-title":"Combining brain imaging and pharmacogenetics in understanding clinical response in Alzheimer\u2019s disease and schizophrenia","author":"Potkin","year":"2002"},{"issue":"12","key":"10.1016\/j.cpet.2026.05.007_bib48","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1176\/appi.ajp.2011.11010160","article-title":"Dopamine synthesis capacity before onset of psychosis: a prospective [18F]-DOPA PET imaging study","volume":"168","author":"Howes","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"10","key":"10.1016\/j.cpet.2026.05.007_bib49","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1038\/s41380-018-0042-4","article-title":"Determinants of treatment response in first-episode psychosis: an 18F-DOPA PET study","volume":"24","author":"Jauhar","year":"2019","journal-title":"Mol Psychiatry"},{"issue":"1","key":"10.1016\/j.cpet.2026.05.007_bib50","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/npp.2009.110","article-title":"Neurocircuitry of addiction","volume":"35","author":"Koob","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cpet.2026.05.007_bib51","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/nn1579","article-title":"Neural systems of reinforcement for drug addiction: from actions to habits to compulsion","volume":"8","author":"Everitt","year":"2005","journal-title":"Nat Neurosci"},{"issue":"Suppl 1","key":"10.1016\/j.cpet.2026.05.007_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.neuropharm.2004.07.019","article-title":"The addicted human brain viewed in the light of imaging studies: brain circuits and treatment strategies","volume":"47","author":"Volkow","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.cpet.2026.05.007_bib53","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.neuroimage.2012.08.057","article-title":"Acute alcohol intoxication decreases glucose metabolism but increases acetate uptake in the human brain","volume":"64","author":"Volkow","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/j.cpet.2026.05.007_bib54","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuropharm.2013.07.039","article-title":"The effects of acute alcohol administration on the human brain: insights from neuroimaging","volume":"84","author":"Bjork","year":"2014","journal-title":"Neuropharmacology"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.007_bib55","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pscychresns.2007.04.010","article-title":"Moderate doses of alcohol disrupt the functional organization of the human brain","volume":"162","author":"Volkow","year":"2008","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.cpet.2026.05.007_bib56","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/acer.14845","article-title":"Fluorodeoxyglucose positron emission tomography scans in patients with alcohol use disorder","volume":"46","author":"Bralet","year":"2022","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.cpet.2026.05.007_bib57","doi-asserted-by":"crossref","DOI":"10.1002\/syn.70007","article-title":"Measuring alcohol-induced striatal dopamine release in healthy humans with [11C]-Raclopride: a meta-analysis","volume":"79","author":"Kania","year":"2025","journal-title":"Synapse"},{"key":"10.1016\/j.cpet.2026.05.007_bib58","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002902","article-title":"Alcohol consumption induces endogenous opioid release in the human orbitofrontal cortex and nucleus accumbens","volume":"4","author":"Mitchell","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.cpet.2026.05.007_bib59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/B978-0-444-62619-6.00018-5","article-title":"Molecular imaging in alcohol dependence","volume":"125","author":"Ravan","year":"2014","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.cpet.2026.05.007_bib60","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1038\/mp.2012.100","article-title":"Reduced cannabinoid CB1 receptor binding in alcohol dependence measured with positron emission tomography","volume":"18","author":"Hirvonen","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib61","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41398-017-0066-6","article-title":"Metabotropic glutamate receptor 5 binding in male patients with alcohol use disorder","volume":"8","author":"Akkus","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib62","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00259-019-04487-1","article-title":"Brain 18FDG-PET pattern in patients with alcohol-related cognitive impairment","volume":"47","author":"Clergue-Duval","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.cpet.2026.05.007_bib63","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/npp.1994.18","article-title":"Buprenorphine reduces cerebral glucose metabolism in polydrug abusers","volume":"10","author":"Walsh","year":"1994","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cpet.2026.05.007_bib64","doi-asserted-by":"crossref","first-page":"E295","DOI":"10.1503\/jpn.220171","article-title":"Abnormal cerebral metabolism and metabolic connectivity in individuals with heroin dependence: an integrated resting-state PET\/fMRI study in large-scale networks","volume":"48","author":"Jin","year":"2023","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.cpet.2026.05.007_bib65","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.drugalcdep.2007.03.015","article-title":"Cerebral metabolism and mood in remitted opiate dependence","volume":"90","author":"Galynker","year":"2007","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.007_bib66","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.drugalcdep.2009.04.022","article-title":"Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging results","volume":"104","author":"Prosser","year":"2009","journal-title":"Drug Alcohol Depend"},{"issue":"3","key":"10.1016\/j.cpet.2026.05.007_bib67","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.biopsych.2011.08.024","article-title":"Deficits in dopamine D(2) receptors and presynaptic dopamine in heroin dependence: commonalities and differences with other types of addiction","volume":"71","author":"Martinez","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib68","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1192\/bjp.bp.106.031120","article-title":"Brain opioid receptor binding in early abstinence from opioid dependence: positron emission tomography study","volume":"191","author":"Williams","year":"2007","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib69","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1192\/bjp.152.5.641","article-title":"Cerebral blood flow in chronic cocaine users: a study with positron emission tomography","volume":"152","author":"Volkow","year":"1988","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib70","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1001\/archpsyc.1990.01810180067010","article-title":"Cocaine-induced reduction of glucose utilization in human brain. A study using positron emission tomography and [fluorine 18]-fluorodeoxyglucose","volume":"47","author":"London","year":"1990","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib71","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/syn.890110303","article-title":"Long-term frontal brain metabolic changes in cocaine abusers","volume":"11","author":"Volkow","year":"1992","journal-title":"Synapse"},{"key":"10.1016\/j.cpet.2026.05.007_bib72","first-page":"51","article-title":"Alteraciones de la perfusi\u00f3n cerebral en consumidores activos de pasta base de coca\u00edna","volume":"73","author":"Ferrando","year":"2009","journal-title":"Rev Psiquiatr Urug"},{"key":"10.1016\/j.cpet.2026.05.007_bib73","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.eurpsy.2019.03.003","article-title":"Effects of stimulant drug use on the dopaminergic system: a systematic review and meta-analysis of in vivo neuroimaging studies","volume":"59","author":"Proebstl","year":"2019","journal-title":"Eur Psychiatry"},{"issue":"11","key":"10.1016\/j.cpet.2026.05.007_bib74","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/archneur.64.11.1575","article-title":"Dopamine in drug abuse and addiction: results of imaging studies and treatment implications","volume":"64","author":"Volkow","year":"2007","journal-title":"Arch Neurol"},{"key":"10.1016\/j.cpet.2026.05.007_bib75","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.biopsych.2013.06.026","article-title":"Imaging glutamate homeostasis in cocaine addiction with the metabotropic glutamate receptor 5 positron emission tomography radiotracer [(11)C]ABP688 and magnetic resonance spectroscopy","volume":"75","author":"Martinez","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib76","doi-asserted-by":"crossref","DOI":"10.1111\/adb.13123","article-title":"Lower prefrontal cortical synaptic vesicle binding in cocaine use disorder: an exploratory 11 C-UCB-J positron emission tomography study in humans","volume":"27","author":"Angarita","year":"2022","journal-title":"Addict Biol"},{"key":"10.1016\/j.cpet.2026.05.007_bib77","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0925-4927(96)02817-X","article-title":"Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication","volume":"67","author":"Volkow","year":"1996","journal-title":"Psychiatry Res Neuroimaging"},{"key":"10.1016\/j.cpet.2026.05.007_bib78","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00213-008-1075-1","article-title":"Cerebral glucose metabolism and D2\/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography","volume":"197","author":"Sevy","year":"2008","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.cpet.2026.05.007_bib79","doi-asserted-by":"crossref","first-page":"E3149","DOI":"10.1073\/pnas.1411228111","article-title":"Decreased dopamine brain reactivity in marijuana abusers is associated with negative emotionality and addiction severity","volume":"111","author":"Volkow","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cpet.2026.05.007_bib80","first-page":"60","article-title":"Rapid changes in cannabinoid 1 receptor availability in cannabis-dependent male subjects after abstinence from cannabis","volume":"1","author":"D\u2019Souza","year":"2016","journal-title":"Biol Psychiatry Cogn Neurosci Neuroimaging"},{"key":"10.1016\/j.cpet.2026.05.007_bib81","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/jnnp.55.9.768","article-title":"Regional cerebral blood flow abnormalities in depressed patients with cognitive impairment","volume":"55","author":"Dolan","year":"1992","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2024.1322118","article-title":"The utility of PET imaging in depression","volume":"15","author":"Singh","year":"2024","journal-title":"Front Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib83","doi-asserted-by":"crossref","first-page":"7019","DOI":"10.1073\/pnas.90.15.7019","article-title":"Regional cerebral glucose metabolism in late-life depression and Alzheimer disease: a preliminary positron emission tomography study","volume":"90","author":"Kumar","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.cpet.2026.05.007_bib84","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41398-021-01539-9","article-title":"Positron emission tomography imaging of serotonin degeneration and beta-amyloid deposition in late-life depression evaluated with multi-modal partial least squares","volume":"11","author":"Smith","year":"2021","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib85","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1038\/s41386-020-0725-9","article-title":"Lowered endogenous mu-opioid receptor availability in subclinical depression and anxiety","volume":"45","author":"Nummenmaa","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.cpet.2026.05.007_bib86","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1001\/jama.1987.03400100102031","article-title":"The differential diagnosis of depression. Relevance of positron emission tomography studies of cerebral glucose metabolism to the bipolar-unipolar dichotomy","volume":"258","author":"Schwartz","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.cpet.2026.05.007_bib87","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/S0006-3223(00)00962-8","article-title":"Increased anterior cingulate and caudate activity in bipolar mania","volume":"48","author":"Blumberg","year":"2000","journal-title":"Biol Psychiatry"},{"issue":"5","key":"10.1016\/j.cpet.2026.05.007_bib88","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jpsychires.2008.08.001","article-title":"Corticolimbic metabolic dysregulation in euthymic older adults with bipolar disorder","volume":"43","author":"Brooks","year":"2009","journal-title":"J Psychiatr Res"},{"issue":"7","key":"10.1016\/j.cpet.2026.05.007_bib89","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1038\/s41380-023-01974-8","article-title":"Prefrontal, parietal, and limbic condition-dependent differences in bipolar disorder: a large-scale meta-analysis of functional neuroimaging studies","volume":"28","author":"Schumer","year":"2023","journal-title":"Mol Psychiatry"},{"issue":"2","key":"10.1016\/j.cpet.2026.05.007_bib90","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.pscychresns.2009.08.006","article-title":"Metabolic evidence of corticolimbic dysregulation in bipolar mania","volume":"181","author":"Brooks","year":"2010","journal-title":"Psychiatry Res"},{"issue":"1","key":"10.1016\/j.cpet.2026.05.007_bib91","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41398-022-01990-2","article-title":"Application of positron emission tomography in Psychiatry\u2014methodological developments and future directions","volume":"12","author":"Cervenka","year":"2022","journal-title":"Transl Psychiatry"},{"key":"10.1016\/j.cpet.2026.05.007_bib92","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1093\/brain\/awaa018","article-title":"Recommendations to distinguish behavioural variant frontotemporal dementia from psychiatric disorders","volume":"143","author":"Ducharme","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.cpet.2026.05.007_bib93","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3233\/JAD-160285","article-title":"Diagnostic accuracy of MRI and additional [18F]FDG-PET for behavioral variant frontotemporal dementia in patients with late onset behavioral changes","volume":"53","author":"Vijverberg","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.cpet.2026.05.007_bib94","doi-asserted-by":"crossref","first-page":"695","DOI":"10.3233\/JAD-150302","article-title":"Clinical impact of a second FDG-PET in atypical\/unclear dementia syndromes","volume":"49","author":"Bergeron","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"10.1016\/j.cpet.2026.05.007_bib95","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1053\/j.semnuclmed.2025.04.007","article-title":"18F-FDG PET for dementia evaluation: co-pathologies, new diseases, and its roles in the era of antiamyloid treatment","volume":"55","author":"Thientunyakit","year":"2025","journal-title":"Semin Nucl Med"},{"issue":"1","key":"10.1016\/j.cpet.2026.05.007_bib96","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40345-024-00366-3","article-title":"Brain 18FDG-PET pattern in cognitively impaired elderly patients with bipolar disorder","volume":"12","author":"Saleh","year":"2024","journal-title":"Int J Bipolar Disord"},{"key":"10.1016\/j.cpet.2026.05.007_bib97","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.3390\/jpm11111183","article-title":"Characteristics of bipolar patients with cognitive impairment of suspected neurodegenerative origin: a multicenter cohort","volume":"11","author":"Musat","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/j.cpet.2026.05.007_bib98","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/RLU.0000000000005574","article-title":"Regional metabolic abnormalities in autoimmune encephalitis: a meta-analysis of 498 cases with brain FDG PET","volume":"50","author":"Kosek","year":"2025","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.cpet.2026.05.007_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.comppsych.2024.152480","article-title":"Role of F-18 FDG PET-CT in neuropsychiatric systemic lupus erythematosus","volume":"132","author":"Berndorfler","year":"2024","journal-title":"Compr Psychiatry"},{"issue":"9","key":"10.1016\/j.cpet.2026.05.007_bib100","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1007\/s00259-021-05215-4","article-title":"18F-FDG brain PET hypometabolism in patients with long COVID","volume":"48","author":"Guedj","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["PET Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826000520?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1556859826000520?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:39:33Z","timestamp":1788449973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1556859826000520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":99,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S1556859826000520"],"URL":"https:\/\/doi.org\/10.1016\/j.cpet.2026.05.007","relation":{},"ISSN":["1556-8598"],"issn-type":[{"value":"1556-8598","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"18F-fluorodeoxyglucose PET in Major Psychiatric Disorders","name":"articletitle","label":"Article Title"},{"value":"PET Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpet.2026.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}